CAS 1092351-10-4

8-[4-[4-(4-Chlorophenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine

Description:

8-[4-[4-(4-Chlorophenyl)piperazide-1-sulfonyl]phenyl]-1-propylxanthine is a synthetic compound that belongs to the class of xanthine derivatives. This substance is characterized by its complex structure, which includes a xanthine core modified with a propyl group and a sulfonamide moiety linked to a piperazine ring. The presence of the 4-chlorophenyl group enhances its pharmacological properties, potentially influencing its interaction with biological targets. The compound is primarily studied for its potential therapeutic applications, particularly in the fields of neuroscience and pharmacology, where it may act as an antagonist or modulator of certain receptors. Its solubility, stability, and bioavailability are critical factors that determine its efficacy in biological systems. As with many synthetic compounds, understanding its mechanism of action, toxicity, and metabolic pathways is essential for evaluating its safety and effectiveness in clinical settings. Overall, this compound represents a significant interest in medicinal chemistry due to its unique structural features and potential biological activities.

Formula: C₂₄H₂₅ClN₆O₄S

Synonyms:

• PSB 603
• 1H-Purine-2,6-dione, 8-[4-[[4-(4-chlorophenyl)-1-piperazinyl]sulfonyl]phenyl]-3,9-dihydro-1-propyl-
• 8-[4-[4-(4-Chlorophenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine
• PSB-603 >=98% (HPLC)

PSB-603

CAS: 1092351-10-4

PSB-603

Purity: ≥95%

Molecular weight: 529.01g/mol

Ref: 54-BUP08306

PSB-603

CAS: 1092351-10-4

PSB-603 is a small molecule that inhibits the P2Y receptors, which are involved in signal transduction pathways. It has been shown to induce neuronal death by inhibiting the activation of Epidermal Growth Factor Receptor (EGFR) and downstream signaling pathways. PSB-603 has also been shown to have anticancer activity in prostate cancer cells, as well as other types of cancer cells. PSB-603 inhibits proliferation and induces apoptosis in prostate cancer cells through inhibition of EGFR and cAMP levels. The mechanism of action for this drug is not fully understood, but it is thought that it may block transcription or translation processes.

Formula: C₂₄H₂₅ClN₆O₄S

Purity: Min. 95%

Molecular weight: 529.01 g/mol

Ref: 3D-STB35110

PSB-603

CAS: 1092351-10-4

PSB-603 is a selective antagonist of Adenosine A2B receptor(Ki = 0.553 nM) with anti-inflammatory effects.

Formula: C₂₄H₂₅ClN₆O₄S

Purity: 97.13%

Color and Shape: Solid

Molecular weight: 529.01

Ref: TM-T23203